Pfizer (PFE) Land & Improvements (2009 - 2011)

Pfizer (PFE) has reported Land & Improvements for 3 consecutive years, with $747.0 million the latest figure, recorded in Q4 2011.

• On a quarterly basis, Land & Improvements fell 5.56% year-over-year to $747.0 million in Q4 2011; TTM through Dec 2011 was $747.0 million, a 5.56% decrease from a year earlier, with the FY2011 full-year figure at $747.0 million, down 5.56% from the prior year.
• Land & Improvements was $747.0 million for Q4 2011 at Pfizer, down from $791.0 million in the prior quarter.
• Over five years, Land & Improvements peaked at $937.0 million in Q4 2009 and troughed at $747.0 million in Q4 2011.
• A 3-year average of $825.0 million and a median of $791.0 million in 2010 frame the typical range for Land & Improvements.
• Across the five-year window, Land & Improvements declined 15.58% in 2010 and slipped 5.56% in 2011, its largest moves.
• Over 3 years, Land & Improvements stood at $937.0 million in 2009, then retreated by 15.58% to $791.0 million in 2010, then decreased by 5.56% to $747.0 million in 2011.
• The last three Land & Improvements figures came in at $747.0 million (Q4 2011), $791.0 million (Q4 2010), and $937.0 million (Q4 2009), per Business Quant data.